Market Overview

Cooler-than-expected June CPI (3.5% YoY vs. expectations) is giving markets a lift, combining with strong big bank earnings (JPM +2%) and a blowout ASML report to fuel risk appetite. The semiconductor equipment space is leading with ASML’s raised guidance and AEHR’s record bookings, while financials are hitting new highs. PPI data due today will either confirm or challenge the disinflation narrative.

Claude’s Call

UP — The CPI surprise removes the nearest-term overhang for bulls, bank earnings are confirming economic resilience, and semis are providing leadership. This tape wants higher into Q2 earnings season unless PPI throws a curveball this morning.

Top Movers

MESO (+7.5%) — $17.97 → $20.50 (+14.1% upside) Thesis: No company-specific catalyst today — this is a speculative biotech catching a bid on general risk-on sentiment and short covering after a +25.7% weekly run. Without a clinical readout or approval catalyst, this is pure momentum trading in a low-float name. I’d be cautious chasing here; biotech rallies without news tend to mean-revert quickly. Levels: Exit at $20.50 (prior resistance zone). Support at $15.50 (pre-rally consolidation level).

AEHR (+7.0%) — $100.46 → $115.00 (+14.5% upside) Thesis: This is the real deal today — record $60.7M in Q4 bookings, revenue beat, and management highlighting AI/data center demand as structural drivers for semiconductor test equipment. The stock was up 32% premarket and is now consolidating the gap-up. The AI capex supercycle is providing a genuine secular tailwind here, not just hype. With ASML also beating and raising, the entire semi-equipment complex has validation. Levels: Exit at $115 (round number psychological resistance). Support at $90 (pre-earnings close/gap fill level).

CSIQ (+6.6%) — $16.21 → $18.50 (+14.1% upside) Thesis: Solar sector is catching a coordinated bid on Wells Fargo’s bullish note plus the Chinese inverter ban speculation benefiting domestic-oriented names. Russell index inclusion in late June is driving passive flows. At these levels, CSIQ is dirt cheap on EV/Revenue relative to FSLR, though the balance sheet quality gap justifies some discount. Levels: Exit at $18.50 (6-month resistance). Support at $14.50 (recent breakout level).

AMC (+6.6%) — $2.09 → $2.30 (+10.0% upside) Thesis: Fresh analyst coverage (appears in today’s top Wall Street calls) plus the $200M capital raise at $2.00 providing a near-term floor. This is still a dilution machine — they just sold 95.25M shares last month — and the fundamental story hasn’t changed. The move is likely short-covering and retail enthusiasm rather than anything structural. Classic penny stock trap for anyone who overstays. Levels: Exit at $2.30 (recent range high). Support at $1.87 (yesterday’s close/offering price floor at $2.00).

CG (+4.8%) — $46.79 → $52.00 (+11.1% upside) Thesis: Carlyle is bouncing hard off deeply oversold levels (RSI 3.3!) after completing the BASF coatings deal for €7.7B and putting Very Group up for sale. The alternative asset manager space is getting a bid as XLF hits new highs. At RSI 3.3, this is a textbook oversold bounce — the question is whether it’s dead-cat or start of recovery. The deal pipeline activity suggests the latter. Levels: Exit at $52 (prior support now resistance). Support at $44.50 (recent swing low).

OWL (+2.7%) — $9.88 → $11.50 (+16.4% upside) Thesis: Meta’s $50B+ Hyperion data center expansion directly names Blue Owl as a JV partner in AI infrastructure financing. This is a real, tangible catalyst — private credit firms funding hyperscale data centers is the exact intersection of the two hottest institutional themes. RSI at 4.4 suggests this has been brutally oversold and is just beginning to recover on fundamental news flow. Levels: Exit at $11.50 (50-day MA zone). Support at $9.25 (recent low).

Headlines to Watch

  • CPI comes in below expectations at 3.5% YoY — This is the most market-moving data point of the week; confirmation from PPI today could cement September rate cut expectations.
  • ASML beats Q2 and raises full-year guidance — Validates the AI capex cycle narrative and provides air cover for the entire semi-equipment food chain (AEHR, KLAC, LRCX, AMAT).
  • Meta expands Hyperion data center to $50B+ — The AI infrastructure buildout continues to accelerate; picks-and-shovels plays (OWL, GHM for cooling) are direct beneficiaries.
  • Traders bet 88% chance S&P 500 will plunge soon — Contrarian signal worth noting; prediction markets showing extreme fear while markets make new highs often marks continuation, not tops.
  • IBM suffers worst single-day market cap wipeout since 1987 — Despite WSB bullishness, something went badly wrong. The divergence between retail enthusiasm and price action is a red flag.
  • US-Iran tensions resurface near Strait of Hormuz — Oil spike risk could quickly flip the script on today’s disinflation celebration; watch crude closely.
  • XLF hits new all-time high — Financials leading is historically a healthy market signal; rotation broadening beyond tech is constructive.

Claude’s Top Picks

AEHR (+7.0% today, +50.1% week) — $100.46 → $115.00 (+14.5% upside) Valuation: At ~30x forward earnings on 40%+ projected FY27 revenue growth, PEG ratio is sub-1.0 — genuinely cheap for a semi-equipment name with record bookings. Upside: AI data center buildout is creating multi-year demand for semiconductor test systems; $60.7M record bookings and raised guidance give 12+ months of visibility. Risk: +50% in one week means profit-taking is inevitable; a gap-fill to $72 (pre-earnings close) would be a 28% drawdown.

OWL (+2.7% today, +6.9% week) — $9.88 → $11.50 (+16.4% upside) Valuation: Trading at ~12x distributable earnings with a 4%+ dividend yield; cheaper than peers like Ares (APO) and KKR on an earnings-yield basis while growing AUM faster. Upside: Meta JV announcement is a concrete catalyst that validates the digital infrastructure strategy; Kirkwood Infrastructure Group launch adds another growth vector. RSI at 4.4 — this is a spring being released. Risk: Alternative asset managers are sensitive to credit conditions; if rate cut expectations fade, the entire space could rerate lower.

CG (+4.8% today, +8.6% week) — $46.79 → $52.00 (+11.1% upside) Valuation: At ~11x fee-related earnings, Carlyle is the cheapest of the large-cap alt managers (KKR ~22x, APO ~16x, BX ~25x) — significant discount despite similar AUM growth trajectory. Upside: RSI 3.3 is extreme oversold territory combined with active deal announcements (BASF close, Very Group sale, Copia Power); the valuation gap to peers should narrow as realizations pick up. Risk: Carlyle has a history of disappointing on fundraising cadence; if Q2 earnings show outflow acceleration, the value trap deepens.

GHM (+4.4% today, +5.3% week) — $111.76 → $125.00 (+11.8% upside) Valuation: At ~28x forward earnings on 17% revenue growth, reasonable for an industrial with data center cooling exposure and defense tailwinds. Oppenheimer sees margin expansion ahead. Upside: Data center cooling is the picks-and-shovels play for AI infrastructure; full-year revenue was $245M (+17%) with Oppenheimer flagging further production capacity expansion. RSI at 6.3 means this bouncing off extreme oversold. Risk: Small-cap with concentrated revenue streams; any single contract delay could move the stock 10%+ in either direction.

Avoid

MESO (+7.5%) — No company-specific catalyst for a +25.7% weekly move in a speculative biotech. This is pure momentum without fundamental support; biotech names that rip without clinical news almost always give it back within 1-2 weeks. RSI at 50 with neutral momentum suggests the easy money has been made.

AMC (+6.6%) — A company that just diluted shareholders by 95.25M shares at $2.00 three weeks ago is not a swing trade, it’s a slot machine. The stock is fundamentally impaired with chronic dilution and negative free cash flow. Any rally back toward $2.30 gets sold by the institutions who bought the direct offering.

SBET (+2.5%) — RSI at 4.4 looks tempting, but this is down 84% over 3 years and still screens as expensive on market multiples. The EthSystems backing is interesting thematically but the stock is a micro-cap crypto-adjacent name with no clear path to profitability. Catching falling knives in speculative names requires much more conviction than a press release.

WSB Sentiment Check

IBM — WSB says: BULLISH (80% bullish) Claude says: DISAGREE — Something is deeply wrong here. Headlines say IBM just suffered its “worst single-day market cap wipeout since 1987” yet WSB is 80% bullish with 762 mentions. This is classic retail buying-the-dip into a structural downgrade. When the market punishes a stock this violently, there’s usually a reason that takes quarters to resolve. This has all the hallmarks of a value trap that retail loves and institutions are dumping.

MU — WSB says: MIXED (55% bullish) Claude says: PARTIALLY AGREE — Micron benefits from the same AI memory cycle driving AEHR and ASML higher, but 55% bullish reflects appropriate uncertainty. MU is highly cyclical and memory pricing can turn quickly. The “mixed” read is actually the smart take here — it’s not a table-pounder until we see their next earnings confirm the upcycle.

SPCX — WSB says: MIXED (55% bullish) Claude says: DISAGREE — SPCX is a SPAC ETF, and betting on a basket of SPACs in 2026 is either very contrarian or very foolish. The 2,054 upvotes suggest meme energy rather than fundamental conviction. SPACs have been capital destruction vehicles for retail investors since 2021.

MSFT — WSB says: BEARISH (30% bullish) Claude says: DISAGREE — Microsoft bearishness at 30% bullish feels like frustration with a stock that hasn’t kept pace with the NVDA/META trade rather than a genuine fundamental thesis. Azure growth remains robust, the Copilot monetization cycle is early, and MSFT is not expensive at ~30x forward. WSB tends to turn bearish on mega-caps right before they rip.

ASML — WSB says: BULLISH (80% bullish) Claude says: AGREE — For once, WSB is aligned with fundamentals. ASML just beat Q2 and raised full-year guidance. They are the only maker of EUV lithography machines on Earth — a literal monopoly in the most critical link of the semiconductor supply chain. The bull case is straightforward and correct. The 80% bullish read is justified by the earnings print.

Earnings Scorecard

JPM — BEAT (details pending) | Stock: +2.0% | Reported: Recent The reaction was measured and appropriate — JPM is the bellwether for financials and a beat with XLF at all-time highs confirms the sector rotation trade. This isn’t a buy-the-dip because there’s no dip; it’s a hold-for-continuation as the financial sector cycle extends. The +2% move on a stock this large with this much coverage suggests the beat was modestly above expectations rather than a blowout.

AEHR — BEAT (record bookings, revenue above consensus) | Stock: +7% (after +32% premarket) | Reported: Tuesday After Close The stock opened +32% and has given back roughly half that move to settle at +7% on the day — this is healthy price discovery, not a rejection. Record $60.7M bookings with raised FY27 guidance is the kind of inflection point that creates multi-quarter momentum. The pullback from premarket highs is a feature, not a bug — it creates a better entry. Buy-the-dip if it retests $90-95.